Ever Supreme Bio Stock Fundamentals
| 6712 Stock | TWD 177.00 0.50 0.28% |
Ever Supreme Bio fundamentals help investors to digest information that contributes to Ever Supreme's financial success or failures. It also enables traders to predict the movement of Ever Stock. The fundamental analysis module provides a way to measure Ever Supreme's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ever Supreme stock.
Ever |
Ever Supreme Bio Company Current Valuation Analysis
Ever Supreme's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ever Supreme Current Valuation | 14.94 B |
Most of Ever Supreme's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ever Supreme Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ever Supreme Bio has a Current Valuation of 14.94 B. This is 4.02% higher than that of the Healthcare sector and 221.61% higher than that of the Biotechnology industry. The current valuation for all Taiwan stocks is 10.13% higher than that of the company.
Ever Supreme Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ever Supreme's current stock value. Our valuation model uses many indicators to compare Ever Supreme value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ever Supreme competition to find correlations between indicators driving Ever Supreme's intrinsic value. More Info.Ever Supreme Bio is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ever Supreme's earnings, one of the primary drivers of an investment's value.Ever Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ever Supreme's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ever Supreme could also be used in its relative valuation, which is a method of valuing Ever Supreme by comparing valuation metrics of similar companies.Ever Supreme is the top company in current valuation category among its peers.
Ever Fundamentals
| Return On Equity | 1.23 | |||
| Return On Asset | -3.46 | |||
| Profit Margin | 7.53 % | |||
| Operating Margin | (36.15) % | |||
| Current Valuation | 14.94 B | |||
| Shares Outstanding | 61.61 M | |||
| Shares Owned By Insiders | 53.37 % | |||
| Shares Owned By Institutions | 2.19 % | |||
| Price To Book | 10.41 X | |||
| Price To Sales | 81.29 X | |||
| Revenue | 193.26 M | |||
| Gross Profit | (17.95 M) | |||
| EBITDA | (45.37 M) | |||
| Net Income | 14.55 M | |||
| Cash And Equivalents | 1.23 B | |||
| Cash Per Share | 20.04 X | |||
| Total Debt | 36.8 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 22.33 X | |||
| Book Value Per Share | 24.50 X | |||
| Cash Flow From Operations | (54.21 M) | |||
| Earnings Per Share | (1.64) X | |||
| Number Of Employees | 94 | |||
| Beta | 0.2 | |||
| Market Capitalization | 15.71 B |
About Ever Supreme Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ever Supreme Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ever Supreme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ever Supreme Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Ever Supreme Bio Technology Co., Ltd engages in the research and development of cell gene therapies based on immune cells and stem cells. The company was founded in 2016 and is based in Taichung, Taiwan. EVER SUPREME operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 94 people.
Pair Trading with Ever Supreme
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ever Supreme position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ever Supreme will appreciate offsetting losses from the drop in the long position's value.Moving together with Ever Stock
| 0.9 | 4743 | Oneness Biotech | PairCorr |
| 0.91 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.82 | 4174 | OBI Pharma | PairCorr |
Moving against Ever Stock
| 0.81 | 2881A | Fubon Financial Holding | PairCorr |
| 0.81 | 2891 | CTBC Financial Holding | PairCorr |
| 0.79 | 2345 | Accton Technology Corp | PairCorr |
| 0.78 | 2618 | Eva Airways Corp | PairCorr |
| 0.76 | 8284 | Mitake Information | PairCorr |
The ability to find closely correlated positions to Ever Supreme could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ever Supreme when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ever Supreme - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ever Supreme Bio to buy it.
The correlation of Ever Supreme is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ever Supreme moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ever Supreme Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ever Supreme can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Ever Stock Analysis
When running Ever Supreme's price analysis, check to measure Ever Supreme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ever Supreme is operating at the current time. Most of Ever Supreme's value examination focuses on studying past and present price action to predict the probability of Ever Supreme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ever Supreme's price. Additionally, you may evaluate how the addition of Ever Supreme to your portfolios can decrease your overall portfolio volatility.